Sartorius to acquire Albumedix, creating a powerhouse for innovative advanced therapy solutions
The Albumedix Campus in Nottingham, UK will be established as a bio-innovation and cGMP-compliant manufacturing Centre of Excellence in Sartorius.
- The Albumedix Campus in Nottingham, UK will be established as a bio-innovation and cGMP-compliant manufacturing Centre of Excellence in Sartorius.
- Life science group Sartorius will acquire all outstanding shares in Albumedix Ltd. for approx.
- Through this acquisition, Albumedix and Sartorius expand their solution space with complementary technologies and synergetic competencies, to deliver science-enabled solutions for the entire advanced therapy value chain.
- The acquisition confirms a general market shift towards fully defined and high-quality solutions for the manufacturing of advanced therapy products, in which recombinant human albumin is an essential component.